Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy City of London Investment Group (CLIG) by Mark Rogers in The Motley Fool
- Buy Barclays (BARC) by Charlie Keough in The Motley Fool
- Neutral Land Securities Group (LAND) by JP Morgan
- Buy BT Group (BT.A) by Berenberg
- Sell Sage Group (SGE) by Canaccord Genuity
- Buy Secure Trust Bank (STB) by Berenberg
- Speculative Buy Hummingbird Resources (HUM) by Canaccord Genuity
- Hold M&G (MNG) by Berenberg
- Buy FD Technologies Public Limited Company (FDP) by Shore Capital
- Hold Land Securities Group (LAND) by Shore Capital
- Buy Tritax Big Box Reit (BBOX) by Shore Capital
- Buy Devolver Digital, Inc. (DI) Reg S Cat 3/144A (DEVO) by Shore Capital
- Watch Supermarket Income Reit (SUPR) by Jon Smith in The Motley Fool
- Buy Rolls-Royce Holdings (RR.) by Jon Smith in The Motley Fool
- Avoid Proteome Sciences (PRM) by Steve Moore in ShareProphets
- Buy Phoenix Group Holdings (PHNX) by Christopher Ruane in The Motley Fool
- Hold Britvic (BVIC) by Jefferies
- Watch Watches of Switzerland Group (WOSG) by Steve Moore in ShareProphets
- Watch Darktrace (DARK) by Gordon Best in The Motley Fool
Mereo Biopharma Group ADR Representing 5 (0A9G) Share Price
NOTE: This is based on 0 open tips for Mereo Biopharma Group ADR Representing 5 (0A9G)
| Latest Bid : 0.00p | Latest Ask : 0.00p |
| High Today : 0.00p | Low Today : 0.00p |
| This Years High : 0.00p | This Years Low : 0.00p |
| Volume : 0 | MKT Cap : |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Mereo Biopharma Group ADR Representing 5 (0A9G) Overview
Our goal is to build an international biopharmaceutical company developing and commercializing new therapies for oncology and rare diseases based on novel targets with strong scientific and biological rationale. We seek to commercialise some of our therapeutics in certain regions and indications and to partner where significantly more resources are needed to fully exploit the potential of the target.Mereo Biopharma Group ADR Representing 5 (0A9G) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.00p | Latest Ask : 0.00p |
| High Today : 0.00p | Low Today : 0.00p |
| This Years High : 0.00p | This Years Low : 0.00p |
| Volume : 0 | MKT Cap : |
Mereo Biopharma Group ADR Representing 5 Overview
Our goal is to build an international biopharmaceutical company developing and commercializing new therapies for oncology and rare diseases based on novel targets with strong scientific and biological rationale. We seek to commercialise some of our therapeutics in certain regions and indications and to partner where significantly more resources are needed to fully exploit the potential of the target.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.